Reflectant sunscreen beige (Dundee formula) cream
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 14 · Randomised trials: 1 · 1989–2026
Showing the 50 most relevant studies, sorted by most relevant.
Samantha L. Schneider, Henry W. Lim
Photodermatology Photoimmunology & Photomedicine, 2018
- Environment
- Sunscreening Agents
- Titanium
Ewa Baranowska‐Wójcik, Dominik Szwajgier, Patryk Oleszczuk, et al.
Biological Trace Element Research, 2019
- Food Coloring Agents
- Inflammation
- Organ Specificity
Happy Agarwal, S. Venkat Kumar, Shanmugam Rajeshkumar
Resource-Efficient Technologies, 2017
Miller RS, Goodnough R, Durrani TS
2025
IntroductionHuman exposure to nanoparticles is increasing due to their widespread use in industry and consumer products. The unique physicochemical properties of these materials lead to novel toxicological effects, primarily driven by the induction of oxidative stress and inflammation, establishing nanotoxicology as a critical public health field. This scoping review synthesizes the current evidence from preclinical models to provide an overview of the mechanisms and end-organ toxicities associated with exposure to metal-containing nanoparticles.MethodsA scoping review was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The PubMed database was searched on August 11, 2024, using a detailed search string focused on nanoparticle inhalation, human toxicity, and metals. Inclusion criteria specified English-language articles reporting on in vivo or in vitro human tissue studies, while studies that were animal-only, reviews, or non-toxicological modeling were excluded.ResultsThe initial search yielded 946 records; ultimately, 136 articles were analyzed based on the inclusion and exclusion criteria. A thematic analysis of the included studies reveals that research is heavily concentrated on the respiratory, gastrointestinal, and immune systems, with titanium dioxide and zinc oxide being the most frequently investigated nanoparticles. Across all organ systems, the principal mechanisms of toxicity were consistently identified as the generation of reactive oxygen species and the initiation of inflammatory cascades. Key organ-specific findings include disruption of the respiratory epithelial barrier, nanoparticle translocation to the cardiovascular and nervous systems, associated mitochondrial damage and protein aggregation, and dose-dependent genotoxicity, including DNA strand breaks and micronuclei formation.DiscussionThe toxicity of metal-containing nanoparticles is highly dependent on their specific physicochemical characteristics, including size, chemical composition, and agglomeration state. While in vitro models have been invaluable for elucidating these mechanistic pathways, significant limitations remain, including a lack of standardization and challenges in translating findings to clinical outcomes in humans. Future research should focus on validating advanced, reproducible models, investigating complex mixed exposures, and identifying sensitive biomarkers to better inform risk assessment and protect public health.Clinical trial numberNot applicable.
Abstract licence: CC BY-NC-ND
Paul P, Kabi S, Biswas J, et al.
2026
Titanium dioxide (TiO2) and Zinc Oxide (ZnO) are two wide-bandgap (Eg) materials (Eg ~3 to 3.3 eV) that have gained significant interest from researchers and are extensively studied in the field of optoelectronics due to their functionality in the UV region. In addition to having a bandgap corresponding to UV radiation, these metal oxides are also considered environmentally friendly, have a cost-effective synthesis and device fabrication mode, and are exhibiting strong physical and chemical stability against external environmental degradation. As observed, the bulk forms of TiO2 and ZnO operate in the UV region due to their favourable band gap. However, as they are downsized to the nanometre range, with varied sizes and morphologies, they can be tuned to work for a broader spectrum of wavelengths, i.e., in the UV-Vis region. Furthermore, in addition to nanostructured metal oxides, incorporating them as heterostructures can improve the overall working efficiency of fabricated devices. Reduced graphene oxide (rGO) is one such integrant that can be included in the heterostructure configuration, due to its stability and ability to boost efficiency owing to its tuneable low bandgap (Eg ~ 1 to 1.2 eV), dependent on its level of reduction, which aids in quicker charge transfer. The central research question that has been explored in this review is how the structural and morphological changes in TiO2, ZnO and rGO are influenced by the synthesis parameters, while also examining various fabrication techniques for constructing heterostructures and investigating how different heterostructure designs impact the UV-detection performance of TiO2, ZnO and ZnO or TiO2/rGO based photodetectors. In this review, we are presenting how the structural and morphological changes in TiO2, ZnO, and rGO affect the detection efficiency of photodetectors operating in the UV-Vis region, and how the heterostructures configured by these materials further influencing the performance.
Abstract licence: CC BY-NC-ND
Zhang Y, Chen J, Zhang J, et al.
2026
This systematic review assesses the necessity of in vivo models in determining whether these novel dual-biofunctional coating could induce osseointegration and exhibit antibacterial activity by providing a comprehensive biological response that in vitro models cannot replicate. This systematic review included in vivo studies involving intraoral implantation. A comprehensive search of original research published in English up to December 2024 was conducted across Medline, Scopus, and Web of Science. From the screened studies, 16 studies (1 clinical trial and 15 animal studies) met the inclusion criteria. The clinical trial involved 15 patients and reported 4-month outcomes. A large variance was observed among the protocol of animal studies, comprising five species (rats, rabbits, dogs, pigs, and goats). Six studies utilized peri-implantitis models to evaluate osseointegration outcomes under disease challenge. The reviewed studies highlighted various osseointegration-promoting components, such as inorganic compounds (e.g., calcium phosphate), peptides, and metal-based materials, as well as antimicrobial agents including metals, metal oxides, and polymers. By synthesizing in vivo findings, this review seeks to optimize dual-biofunctional coatings that simultaneously eradicate pathogenic bacteria and induce osseointegration within clinically relevant environments. Future work should aim to standardize in vivo protocols and new in vitro methods to reduce heterogeneity.
Abstract licence: CC BY-NC-ND
Kensy J, Kotela A, Wenderski J, et al.
2026
Martínez-Escutia CX, Medina-Reyes EI, Delgado-Armenta E, et al.
2026
- Titanium
- Intestines
- Intestinal Mucosa
Janusz Bogdan, Joanna Pławińska-Czarnak, Joanna Magdalena Zarzynska
Nanoscale Research Letters, 2017
Hongbo Shi, Ruth Magaye, Vincent Castranova, et al.
Particle and Fibre Toxicology, 2013
- Food Contamination
- Intestinal Absorption
- Respiratory System
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.